Pharmacolog i Uppsala AB (publ) announced that Erik Hedlund, acting CEO, returns to the role of chairman of the board and Lars Gusch, previously COO, has been appointed CEO of the company. Pharmacolog's board has entered into a new agreement with current COO Lars Gusch, who will take over as CEO of the company with immediate effect. Lars Gusch was hired as COO at Pharmacolog in January 2022 and was previously development manager for the company in 2019-2020.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0904 SEK | +7.36% |
|
-4.84% | +59.72% |
Jun. 12 | Nolsterby Invest AB Offers A Loan Facility of Up to SEK 25 Million to Perpetua Medical AB | CI |
May. 17 | Perpetua Medical AB Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
1st Jan change | Capi. | |
---|---|---|
+59.72% | 867K | |
-27.55% | 16.26B | |
-50.54% | 2.44B | |
+25.26% | 1.98B | |
-8.81% | 1.52B | |
+26.63% | 1.3B | |
-18.54% | 937M | |
-32.14% | 775M | |
-0.96% | 760M | |
-26.54% | 615M |
- Stock Market
- Equities
- PERP B Stock
- News Pharmacolog i Uppsala AB
- Pharmacolog i Uppsala AB Announces CEO Changes